Rare diseases, defined by FDA as “a disease or condition that affects less than 200,000 people in the United States” (1), may ...
The inaugural Genetic Agency Technology Conference (GATC) on November 11th, 2025 will convene technical thought leaders, gene therapy developers, patients, their families, and patient advocates across ...
Entrepreneurs say it’s time to safety-test designer baby technology. A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback